Intellectual Property in the Life Sciences, in review
Life Sciences Issues in Corporate Transactions - Part 1
by Colin McCall
Countdown to the UPC - Opt-out and the transitional period
by Dr Paul England and Verena Bertram
Upgrading the single market: updating the Bolar exemption
Largest damages award on cross-undertaking upheld on appeal
Countdown to the UPC - Decisions the UPC can make and how it makes them
by multiple authors